AI Summary & Key Takeaways
AI InsightThe mostimportant decision triangle is the patient's acceptance (A), family support (B), and tracheostomy indication (C), and this may vary fromcountry to country depending on the beliefs of subjects
📌 3 Key Takeaways
Özet
OBJECTIVES: Tracheostomy is a method of separating a patient from the mechanical ventilator in the intensive care unit (ICU). Thelong-term survivors among patients followed up with tracheostomy and ventilator in the respiratory ICU (RICU) outpatient clinic due todifferent diseases were investigated.MATERIALS AND METHODS: This was a retrospectively designed cohort study between January 2004 and July 2018. Patients withchronic respiratory failure followed up with tracheostomy and/or ventilator at the RICU outpatient clinic were included in the study. Age,gender, indications and date of tracheostomy, use of domestic mechanical ventilation, and mortality were recorded. The groups werecompared according to age, gender, and tracheostomy indication diseases, and the 1–3-year long-term mortality rates were analyzed bythe Kaplan–Meier survival analysis, and the Cox regression test was performed.RESULTS: A total of 134 (64% male) patients with a median age of 66 (54–73) years were included in the study. The indications for tracheostomy were heart failure (HF) and cerebrovascular diseases (38.1%), chronic obstructive pulmonary disease (COPD) (23.1%), neuromuscular diseases (22.4%), obesity hypoventilation (9.7%), and kyphoscoliosis (6.7%). Mortality was higher in patients >75 years oldin the 3-year follow-up (p=0.022). The 3-year mortality hazard ratio (HR) factors and 95% confidence interval (CI) were as follows: age>75 years HR=1.71 (95% CI, 1.03–2.82; p<0.036) and HF and cerebrovascular disease diseases sequela HR=1.84 (95% CI, 1.03–3.29;p<0.041) significantly increased the 3-year mortality, and having COPD decreased mortality in 46% (p<0.041).CONCLUSION: Patients with neuromuscular disorders, kyphoscoliosis, and COPD who have undergone tracheostomy were the luckiestgroup according to the 3-year survival rates, whereas patients with HF and cerebrovascular diseases were the unluckiest ones. The mostimportant decision triangle is the patient's acceptance (A), family support (B), and tracheostomy indication (C), and this may vary fromcountry to country depending on the beliefs of subjects